AARTI PHARMALABS
|
AARTI PHARMALABS Last 5 Year Balance Sheet History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|
EQUITY AND LIABILITIES | |||
Share Capital | ₹45 Cr | ₹0.25 Cr | ₹0.25 Cr |
Equity - Authorised | ₹50 Cr | ₹0.50 Cr | ₹0.50 Cr |
Equity - Issued | ₹45 Cr | ₹0.25 Cr | ₹0.25 Cr |
Equity Paid Up | ₹45 Cr | ₹0.25 Cr | ₹0.25 Cr |
Equity Shares Forfeited | - | - | - |
Adjustments to Equity | - | - | - |
Preference Capital Paid Up | - | - | - |
Face Value | ₹5.00 | ₹10.00 | ₹10.00 |
Share Warrants & Outstandings | - | ₹45 Cr | - |
Total Reserves | ₹1,513 Cr | ₹1,341 Cr | ₹-0.02 Cr |
Securities Premium | ₹440 Cr | ₹440 Cr | - |
Capital Reserves | ₹89 Cr | ₹89 Cr | - |
Profit & Loss Account Balance | ₹889 Cr | ₹717 Cr | ₹-0.02 Cr |
General Reserves | ₹85 Cr | ₹83 Cr | - |
Other Reserves | ₹8.77 Cr | ₹11 Cr | - |
Reserve excluding Revaluation Reserve | ₹1,513 Cr | ₹1,341 Cr | ₹-0.02 Cr |
Revaluation reserve | - | - | - |
Shareholder's Funds | ₹1,558 Cr | ₹1,386 Cr | ₹0.23 Cr |
Minority Interest | - | - | - |
Long-Term Borrowings | - | - | - |
Secured Loans | ₹0.18 Cr | ₹0.56 Cr | - |
Non Convertible Debentures | - | - | - |
Converible Debentures & Bonds | - | - | - |
Packing Credit - Bank | - | - | - |
Inter Corporate & Security Deposit | - | - | - |
Term Loans - Banks | - | - | - |
Term Loans - Institutions | - | - | - |
Other Secured | ₹0.18 Cr | ₹0.56 Cr | - |
Unsecured Loans | - | - | - |
Fixed Deposits - Public | - | - | - |
Loans and advances from subsidiaries | - | - | - |
Inter Corporate Deposits (Unsecured) | - | - | - |
Foreign Currency Convertible Notes | - | - | - |
Long Term Loan in Foreign Currency | - | - | - |
Loans - Banks | - | - | - |
Loans - Govt. | - | - | - |
Loans - Others | - | - | - |
Other Unsecured Loan | - | - | - |
Deferred Tax Assets / Liabilities | ₹79 Cr | ₹71 Cr | - |
Deferred Tax Assets | ₹7.80 Cr | - | - |
Deferred Tax Liability | ₹87 Cr | ₹71 Cr | - |
Other Long Term Liabilities | ₹0.53 Cr | ₹1.53 Cr | - |
Long Term Trade Payables | - | - | - |
Long Term Provisions | ₹1.32 Cr | - | - |
Total Non-Current Liabilities | ₹81 Cr | ₹73 Cr | - |
Current Liabilities | - | - | - |
Trade Payables | ₹347 Cr | ₹215 Cr | ₹0.00 Cr |
Sundry Creditors | ₹347 Cr | ₹215 Cr | ₹0.00 Cr |
Acceptances | - | - | - |
Due to Subsidiaries- Trade Payables | - | - | - |
Other Current Liabilities | ₹17 Cr | ₹12 Cr | ₹0.00 Cr |
Bank Overdraft / Short term credit | - | - | - |
Advances received from customers | - | - | - |
Interest Accrued But Not Due | - | - | - |
Share Application Money | - | - | - |
Current maturity of Debentures & Bonds | - | - | - |
Current maturity - Others | - | - | - |
Other Liabilities | ₹17 Cr | ₹12 Cr | ₹0.00 Cr |
Short Term Borrowings | ₹214 Cr | ₹338 Cr | ₹0.02 Cr |
Secured ST Loans repayable on Demands | ₹193 Cr | ₹13 Cr | - |
Working Capital Loans- Sec | ₹193 Cr | ₹13 Cr | - |
Buyers Credits - Unsec | - | - | - |
Commercial Borrowings- Unsec | - | - | - |
Other Unsecured Loans | ₹-172 Cr | ₹312 Cr | ₹0.02 Cr |
Short Term Provisions | ₹14 Cr | ₹16 Cr | - |
Proposed Equity Dividend | - | - | - |
Provision for Corporate Dividend Tax | - | - | - |
Provision for Tax | ₹2.90 Cr | ₹7.50 Cr | - |
Provision for post retirement benefits | - | - | - |
Preference Dividend | - | - | - |
Other Provisions | ₹11 Cr | ₹8.96 Cr | - |
Total Current Liabilities | ₹592 Cr | ₹581 Cr | ₹0.02 Cr |
Total Liabilities | ₹2,231 Cr | ₹2,040 Cr | ₹0.25 Cr |
ASSETS | |||
Gross Block | ₹1,431 Cr | ₹1,225 Cr | - |
Less: Accumulated Depreciation | ₹505 Cr | ₹443 Cr | - |
Less: Impairment of Assets | - | - | - |
Net Block | ₹926 Cr | ₹782 Cr | - |
Lease Adjustment A/c | - | - | - |
Capital Work in Progress | ₹62 Cr | ₹165 Cr | - |
Non Current Investments | ₹36 Cr | ₹32 Cr | - |
Long Term Investment | ₹36 Cr | ₹32 Cr | - |
Quoted | - | - | - |
Unquoted | ₹36 Cr | ₹32 Cr | - |
Long Term Loans & Advances | ₹12 Cr | ₹10 Cr | - |
Other Non Current Assets | - | - | - |
Total Non-Current Assets | ₹1,075 Cr | ₹1,012 Cr | - |
Current Assets Loans & Advances | - | - | - |
Currents Investments | ₹38 Cr | - | - |
Quoted | ₹38 Cr | - | - |
Unquoted | - | - | - |
Inventories | ₹602 Cr | ₹475 Cr | - |
Raw Materials | ₹191 Cr | ₹191 Cr | - |
Work-in Progress | ₹140 Cr | ₹90 Cr | - |
Finished Goods | ₹265 Cr | ₹190 Cr | - |
Packing Materials | ₹1.89 Cr | ₹1.15 Cr | - |
Stores Ā and Spare | ₹2.72 Cr | ₹2.31 Cr | - |
Other Inventory | ₹0.74 Cr | ₹1.05 Cr | - |
Sundry Debtors | ₹440 Cr | ₹377 Cr | - |
Debtors more than Six months | ₹20 Cr | ₹9.21 Cr | - |
Debtors Others | ₹420 Cr | ₹367 Cr | - |
Cash and Bank | ₹25 Cr | ₹83 Cr | ₹0.25 Cr |
Cash in hand | ₹0.11 Cr | ₹0.06 Cr | - |
Balances at Bank | ₹25 Cr | ₹83 Cr | ₹0.25 Cr |
Other cash and bank balances | - | - | - |
Other Current Assets | ₹7.58 Cr | ₹11 Cr | - |
Interest accrued on Investments | - | - | - |
Interest accrued on Debentures | - | - | - |
Deposits with Government | - | - | - |
Interest accrued and or due on loans | - | - | - |
Prepaid Expenses | ₹2.33 Cr | ₹4.20 Cr | - |
Other current_assets | ₹5.25 Cr | ₹6.54 Cr | - |
Short Term Loans and Advances | ₹43 Cr | ₹82 Cr | - |
Advances recoverable in cash or in kind | - | - | - |
Advance income tax and TDS | - | - | - |
Amounts due from directors | - | - | - |
Due From Subsidiaries | - | - | - |
Inter corporate deposits | - | - | - |
Corporate Deposits | - | - | - |
Other Loans & Advances | ₹43 Cr | ₹82 Cr | - |
Total Current Assets | ₹1,156 Cr | ₹1,028 Cr | ₹0.25 Cr |
Net Current Assets (Including Current Investments) | ₹564 Cr | ₹447 Cr | ₹0.23 Cr |
Miscellaneous Expenses not written off | - | - | - |
Total Assets | ₹2,231 Cr | ₹2,040 Cr | ₹0.25 Cr |
Contingent Liabilities | ₹0.01 Cr | - | - |
Total Debt | ₹214 Cr | ₹339 Cr | ₹0.02 Cr |
Book Value | 171.97 | 53,646.60 | 9.12 |
Adjusted Book Value | 171.97 | 53,646.60 | 9.12 |
Compare Balance Sheet of peers of AARTI PHARMALABS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AARTI PHARMALABS | ₹5,315.5 Cr | 18.5% | 30.6% | 63% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹366,354.0 Cr | 2.3% | -0.8% | 60.8% | Stock Analytics | |
CIPLA | ₹113,516.0 Cr | 3.5% | 0.7% | 43.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹103,352.0 Cr | 2.7% | 3% | 17.1% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹100,367.0 Cr | 3.1% | 3.8% | 91.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹97,961.5 Cr | -0.1% | -3.5% | 29.5% | Stock Analytics |
AARTI PHARMALABS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AARTI PHARMALABS | 18.5% |
30.6% |
63% |
SENSEX | -0.7% |
-2.7% |
17.8% |
You may also like the below Video Courses